HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis.

Gupta, RK; Gregson, J; Parkin, N; Haile-Selassie, H; Tanuri, A; Andrade Forero, L; Kaleebu, P; Watera, C; Aghokeng, A; Mutenda, N; +23 more... Dzangare, J; Hone, S; Hang, ZZ; Garcia, J; Garcia, Z; Marchorro, P; Beteta, E; Giron, A; Hamers, R; Inzaule, S; Frenkel, LM; Chung, MH; de Oliveira, T; Pillay, D; Naidoo, K; Kharsany, A; Kugathasan, R; Cutino, T; Hunt, G; Avila Rios, S; Doherty, M; Jordan, MR; Bertagnolio, S; (2017) HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis. The Lancet infectious diseases. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(17)30702-8

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1473-3099(17)30702-8

Abstract

Share

Download

Filename: HIV-1 drug resistance before initiation or re-initiation.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar